SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-015779
Filing Date
2024-11-15
Accepted
2024-11-15 07:30:32
Documents
15
Period of Report
2024-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpth-20241115x8k.htm   iXBRL 8-K 41091
2 EX-99.1 bpth-20241115xex99d1.htm EX-99.1 31451
3 GRAPHIC bpth-20241115xex99d1001.jpg GRAPHIC 10795
  Complete submission text file 0001558370-24-015779.txt   215639

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpth-20241115.xsd EX-101.SCH 3291
5 EX-101.LAB bpth-20241115_lab.xml EX-101.LAB 15929
6 EX-101.PRE bpth-20241115_pre.xml EX-101.PRE 10129
17 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20241115x8k_htm.xml XML 4915
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS, INC. (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 241465850
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)